Fold-change (1d postoperation, PND vs Control) | Fold-change (3d postoperation, PND vs Control) | Fold-change (7d postoperation, PND vs Control) | Protein function |
---|---|---|---|
4.04 | 5.29 | 6.93 | Cellular potassium ion homeostasis |
3.47 | 2.63 | 3.11 | Heme binding |
2.38 | 3.14 | 3.73 | Positive regulation of MAP kinase activity Negative regulation of protein catabolic process |
1.99 | 2.24 | 2.83 | Mitochondrial outer membrane |
2.36 | 2.73 | 2.40 | Positive regulation of apoptotic process |
2.59 | 2.29 | 2.01 | Structural constituent of ribosome |
2.23 | 1.76 | 1.89 | Cytoplasm |
2.01 | 2.22 | 1.99 | SNARE binding |
1.79 | 2.01 | 2.08 | Pyruvate metabolism |
1.87 | 1.54 | 1.49 | Structural constituent of ribosome |
1.98 | 1.88 | 1.44 | 1-Phosphatidylinositol binding |
1.36 | 1.76 | 1.68 | Biological process |
0.66 | 0.70 | 0.74 | Proteasome-mediated ubiquitin-dependent protein catabolic process |
0.77 | 0.73 | 0.68 | U1 snRNP binding |
0.72 | 0.68 | 0.67 | Structural constituent of ribosome |
0.63 | 0.68 | 0.79 | Protein binding |
0.59 | 0.80 | 0.73 | Negative regulation of dopamine metabolic process |
0.61 | 0.61 | 0.43 | Structural constituent of ribosome |
0.54 | 0.52 | 0.27 | Nucleus |
0.54 | 0.52 | 0.27 | Nucleus |
0.57 | 0.58 | 0.66 | Biological process |